| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1743 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 395* | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 318 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 223 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 86 | 2022 |
| Performance of intensive care unit severity scoring systems across different ethnicities in the USA: a retrospective observational study R Sarkar, C Martin, H Mattie, JW Gichoya, DJ Stone, LA Celi The Lancet Digital Health 3 (4), e241-e249, 2021 | 63 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 58 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, N Staplin, JR Emberson, M Campbell, ... The Lancet 399 (10320), 143-151, 2021 | 39 | 2021 |
| FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation K Manohar, RK Gupta, P Gupta, D Saha, S Gare, R Sarkar, A Misra, L Giri Free Radical Biology and Medicine 177, 189-200, 2021 | 12 | 2021 |
| Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19 C Martin, S McDonald, S Bale, M Luteijn, R Sarkar BMC medical informatics and decision making 21 (1), 138, 2021 | 10 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv. 2021: 2021.02. 11 … PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas Remdesivir given, 16, 0 | 9 | |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Data Monitoring Committee of the RECOVERY ... Nature Communications 15 (1), 924, 2024 | 8 | 2024 |
| An ML prediction model based on clinical parameters and automated CT scan features for COVID-19 patients A Sinha, SP Joshi, PS Das, S Jana, R Sarkar Scientific Reports 12 (1), 11255, 2022 | 8 | 2022 |
| Effect of routine fiberoptic bronchoscopy and bronchoalveolar lavage on arterial blood gases. SK Sharma, JN Pande, R Sarkar The Indian Journal of Chest Diseases & Allied Sciences 35 (1), 3-8, 1993 | 8 | 1993 |
| Automated quantification of inflamed lung regions in chest CT by UNET++ and SegCaps: a comparative analysis in COVID-19 cases P Bhatia, A Sinha, SP Joshi, R Sarkar, R Ghosh, S Jana 2022 44th Annual International Conference of the IEEE Engineering in …, 2022 | 5 | 2022 |
| RECOVERY Collaborative Group Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): Preliminary Results of a Randomised, Controlled, Open-Label, Platform Trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... MedRxiv, 2021 | 4 | 2021 |
| Three-dimensional tracking of intracellular calcium and redox state during real-time control in a hypoxic gradient in microglia culture: Comparison of the channel blocker and … V Dhyani, S Kumar, SR Manne, I Kaur, S Jana, S Russell, R Sarkar, L Giri ACS Chemical Neuroscience 14 (10), 1810-1825, 2023 | 3 | 2023 |
| Tocilizumab in patients admitted to hospital with COVID-19 (recovery): preliminary results of a randomized, controlled, open-label, platform trial. medRxiv 2021.02. 11.21249258 … RECOVERY Collaborative Group, PW Horby, G Pessoa-Amorim | 3 | 2021 |
| A combined qSOFA-lactate model for sepsis-related mortality prediction: a small step towards an elusive answer? R Sarkar The Lancet Global Health 10 (9), e1214-e1215, 2022 | 2 | 2022 |
| Analytics pipeline for visualization of single cell rna sequencing data from brochoaveolar fluid in covid-19 patients: Assessment of neuro fuzzy-c-means and hdbscan S Gare, S Chel, PD Pantula, A Saxena, K Mitra, R Sarkar, L Giri 2022 44th Annual International Conference of the IEEE Engineering in …, 2022 | 2 | 2022 |
